Verywell Health on MSN1y
Medications for Pulmonary Arterial Hypertension
Medically reviewed by Lindsay Cook, PharmD Pulmonary hypertension (PH) can be challenging for healthcare professionals to diagnose because of its vague symptoms, such as fatigue and shortness of ...
The American Journal of Managed Care12h
PAH Treatment Benefits Extend to Patients With Repaired Congenital Heart Disease
Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...
Pulmonary Hypertension News8h
MTMR7 protein shows promise as PAH treatment in mice
Boosting MTMR7 production reversed signs of pulmonary arterial hypertension in a mouse model of PAH and may serve as a ...
The American Journal of Managed Care1y
2022 ESC/ERS Guideline-Recommended Management of Pulmonary Arterial Hypertension and Agents Under Clinical Development
In treatment-naïve patients with PAH ... this signaling is involved in remodeling of the pulmonary arterial wall and right ventricle. 27,37 Almost all patients in both study groups experienced ...
Pulmonary Arterial Hypertension Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...
Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...
European Medical Journal5d
Sotatercept Shows Long-Term Benefit in Pulmonary Arterial Hypertension Treatment
The ongoing SOTERIA study suggests that sotatercept provides a favourable long-term safety and efficacy profile for adults with pulmonary hypertension.
Pulmonary Hypertension News11d
Pooled trial analysis supports Winrevair as PAH treatment
Adding Winrevair to standard pulmonary arterial hypertension (PAH) treatment is generally safe and effective, a pooled trial ...
Business Wire7d
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...
Medindia4y
Medications and Drugs for Treatment of Pulmonary Arterial Hypertension
Are you searching for effective medications to treat 'Pulmonary Arterial Hypertension'? This comprehensive guide provides the latest information on medications-both generic and branded-that are ...